Emerging Role of Interleukin-38 (IL-38) in the Development of Rheumatoid Arthritis

被引：0
|
作者：
Shengxiang Liang
Liting Chen
Ruilan Liang
Jiayi Ling
Minghui Hou
Song Gao
Minglin Ou
Min Yang
机构：
[1] The Second Affiliated Hospital of Guilin Medical University,Health Management Center, Guangxi Key Laboratory of Metabolic Reprogramming and Intelligent Medical Engineering for Chronic Diseases
[2] The First People’s Hospital of Qinzhou,Department of Rheumatology and Immunology
[3] The Affiliated Hospital of Guilin Medical University,Department of Rheumatology and Immunology
[4] The Affiliated Hospital of Guilin Medical University,Department of Ultrasound
[5] The Second Affiliated Hospital of Guilin Medical University,Central Laboratory, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders
来源：
Rheumatology and Therapy | 2024年 / 11卷
关键词：
Correlation; Interleukin-38; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：349 / 362
页数：13
相关论文
共 50 条
  • [41] Decreased serum IL-38 levels in pemphigus vulgaris
    Yamamoto, Toyoki
    Li, Lixin
    Ito, Yukiko
    Sato, Shinichi
    Shibata, Sayaka
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (07)
  • [42] Interleukin-38 promotes skin tumorigenesis in an IL-1Rrp2-dependent manner
    Zhou, Hong
    Zhao, Qixiang
    Yue, Chengcheng
    Yu, Jiadong
    Zheng, Huaping
    Hu, Jing
    Hu, Zhonglan
    Zhang, Haozhou
    Teng, Xiu
    Liu, Xiao
    Wei, Xiaoqiong
    Zhou, Yuxi
    Zeng, Fanlian
    Hao, Yan
    Hu, Yawen
    Wang, Xiaoyan
    Zhang, Chen
    Gu, Linna
    Wu, Wenling
    Zhou, Yifan
    Cui, Kaijun
    Huang, Nongyu
    Li, Wei
    Wang, Zhen
    Li, Jiong
    EMBO REPORTS, 2022, 23 (06)
  • [43] The role of Interleukin-38 in modulating T cells in chronic Colitis: A mouse model study
    Xu, Ying
    Zhang, Xuan
    Liu, Shanshan
    Qu, Nanfang
    Gao, Yi
    Lu, Changlong
    Zhai, Jingbo
    Zhu, Junfeng
    CYTOKINE, 2024, 184
  • [44] IL-38 promotes anti-inflammatory effects
    Dario Ummarino
    Nature Reviews Rheumatology, 2017, 13 (5) : 260 - 260
  • [45] IL-38 as an early predictor of the ischemic stroke prognosis
    Rafie, Maryam Zare
    Esmaeilzadeh, Abdolreza
    Ghoreishi, Abdolreza
    Tahmasebi, Safa
    Faghihzadeh, Elham
    Elahi, Reza
    CYTOKINE, 2021, 146
  • [46] IL-38: A New Player in Inflammatory Autoimmune Disorders
    Xie, Lihui
    Huang, Zhaohao
    Li, He
    Liu, Xiuxing
    Zheng, Song Guo
    Su, Wenru
    BIOMOLECULES, 2019, 9 (08)
  • [47] IL-38 orchestrates proliferation and differentiation in human keratinocytes
    Mermoud, Loic
    Shutova, Maria
    Diaz-Barreiro, Alejandro
    Talabot-Ayer, Dominique
    Drukala, Justyna
    Wolnicki, Michal
    Kaya, Guerkan
    Boehncke, Wolf-Henning
    Palmer, Gaby
    Borowczyk, Julia
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (11) : 1699 - 1711
  • [48] Effects of IL-38 on Macrophages and Myocardial Ischemic Injury
    Li, Zhiyang
    Ding, Yan
    Peng, Yudong
    Yu, Jian
    Pan, Chengliang
    Cai, Yifan
    Dong, Qian
    Zhong, Yucheng
    Zhu, Ruirui
    Yu, Kunwu
    Zeng, Qiutang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] DISTINCT EXPRESSION OF IL-36α, β, γ AND THEIR ANTAGONISTS IL-36RA AND IL-38 IN PSORIASIS, RHEUMATOID ARTHRITIS (RA) AND CROHN'S DISEASE (CD)
    Boutet, M. A.
    Bart, G.
    Gahier, M.
    Amiaud, J.
    Brulin, B.
    Charrier, C.
    Morel, F.
    Lecron, J-C
    Rolli-Derkinderen, M.
    Boureille, A.
    Vigne, S.
    Gabay, C.
    Palmer, G.
    Le Goff, B.
    Blanchard, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A60 - A61
  • [50] IL-36 RECEPTOR ANTAGONIST WITH SPECIAL EMPHASIS ON IL-38
    Shaik, Y.
    Sabatino, G.
    Maccauro, G.
    Varvara, G.
    Murmura, G.
    Saggini, A.
    Rosati, M.
    Conti, F.
    Cianchetti, E.
    Caraffa, A.
    Antinolfi, P.
    Pandolfi, F.
    Potalivo, G.
    Galzio, R.
    Conti, P.
    Theoharides, T. C.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2013, 26 (01): : 27 - 36
12345